Survival Outcomes in Metastatic Prostate Cancer in the Brazilian Population - Analysis of Individual Characteristics and Treatment Modalities in Different National Health Institutions.
NCT ID: NCT04962919
Last Updated: 2025-02-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
584 participants
OBSERVATIONAL
2020-01-14
2025-05-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management of Metastatic Colorectal Cancer: A Clinical and Patient Perspective
NCT03935763
Molecular and Epidemiological Characteristics of Endometrial Cancer in Brazil
NCT06014580
A Randomised Trial of Pulmonary Metastasectomy in Colorectal Cancer
NCT01106261
Observational Study on Treatment of Metastatic Colorectal Cancer and the Role of K-Ras
NCT01651013
A Retrospective Review of Liver Resection Rate in Metastatic Colorectal Cancer Patients Following Downsizing Treatment With Chemotherapy Plus Cetuximab in Normal UK National Health Service Clinical Practice
NCT01460745
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Public institution
Castration-resistant metastatic prostate cancer diagnosed between January 2014 and December 2017
No interventions assigned to this group
Private institution
Castration-resistant metastatic prostate cancer diagnosed between January 2014 and December 2017
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with medical records filled with incomplete data that make it impossible to evaluate the treatment received.
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Latin American Cooperative Oncology Group
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fernando Cotait Maluf
Role: PRINCIPAL_INVESTIGATOR
Latin American Cooperative Oncology Group
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CPO Pucrs
Porto Alegre, Rio Grande do Sul, Brazil
Centro de Estudos e Pesquisas de Hematologia e Oncologia - CEPHO
Santo André, São Paulo, Brazil
Sírio Libanês
São Paulo, São Paulo, Brazil
Centro Paulista de Oncologia
São Paulo, São Paulo, Brazil
Hospital Santa Marcelina
São Paulo, , Brazil
BP - A Beneficência Portuguesa de São Paulo
São Paulo, , Brazil
Irmandade da Santa Casa de Misericórdia de São Paulo - Hospital Central
São Paulo, , Brazil
A.C.Camargo Cancer Center
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LACOG 1818
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.